KBLB Kraig Biocraft Laboratories Inc.

24/7 Market News- Kraig Labs Eyes Multi-Billion-Dollar Eco-Luxury Apparel Market with Mass-Produced Spider Silk

24/7 Market News- Kraig Labs Eyes Multi-Billion-Dollar Eco-Luxury Apparel Market with Mass-Produced Spider Silk

DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, appears to be positioning itself at the forefront of a potential multi-billion-dollar eco-luxury apparel revolution.

With synthetic spider silk production finally reaching meaningful commercial scale, Kraig Labs is tapping into the convergence of luxury fashion, performance textiles, and sustainability, a space that analysts believe could represent $1.4 to $2.1 billion annually by 2030, and up to $3+ billion by 2035.

An Eco-Luxury Opportunity Years in the Making

Spider silk is renowned for its extraordinary strength-to-weight ratio, elasticity, and biodegradability, qualities that are increasingly prized by high-end designers and performance wear innovators. Yet until recently, one major obstacle held back its commercial potential: scale.

Kraig Labs' proprietary transgenic silkworm technology now offers a scalable, cost-effective path to spider silk production, creating opportunities in apparel that were once science fiction.

For the first time, sustainable spider silk garments may be produced at scale and price points that luxury and other markets can embrace.

As Kraig Labs is ramping up its spider silk production, the Company is positioning its super fibers for early adoption in eco-luxury fashion, premium outdoor gear, and high-performance athletic wear.

Sizing the Market Potential

According to recent market analyses:

  • If synthetic spider silk becomes a $7 billion market by 2030, with 20–30% allocated to apparel, that suggests $1.4–$2.1 billion in annual fashion revenue.
  • As costs drop and adoption grows, that could expand to $2–3+ billion by 2035.
  • Within the broader $250–$330 billion global luxury apparel market, spider silk garments capturing even 0.5–1% share could generate $1.25–$3.3 billion in sales.

Kraig Labs is ideally positioned to lead this eco-material wave, especially as environmental scrutiny increases across the fashion supply chain. The company’s production platform leverages existing silkworm farming infrastructure, giving it a clear path to both scale and pricing competitiveness.

For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit

Please to read the full Kraig Labs analyst report on 247marketnews.com.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.

For more information, please visit:

Contact for Analyst Report coverage and other investor/public relations services.

About 24/7 Market News

24/7 Market News (247) is a leading market news platform for public companies. As a pioneer in digital media, 247 is dedicated to the swift distribution of financial market news and information. 247 takes great pride in creating innovative public relations campaigns that help clients reach the target audience.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer . Please go to for further KBLB and 247marketnews.com disclosure information.

CONTACT:

24/7 Market News

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.



EN
29/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets A...

From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk DENVER, April 02, 2026 (GLOBE NEWSWIRE) -- () -- Kraig Biocraft Laboratories (OTCQB: KBLB) is advancing a transgenic silkworm platform designed to produce recombinant spider silk at commercial scale, positioning the company at the intersection of genetic engineering, materials science, and textile manufacturing. Spider silk has long been studied for its combination of strength, elasticity, and low weight. The challenge has been producing it economically at scale. Kraig’s approac...

 PRESS RELEASE

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Productio...

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan ANN ARBOR, Mich., March 30, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory. These silkworms are now in active production. This achievement underscores the Company's continued execution of its previou...

 PRESS RELEASE

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas B...

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics ANN ARBOR, Mich., March 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a significant expansion of its research and development capacity designed to keep pace with rapid progress of its advanced materials initiative, Project Atlas. The Company has expanded its laboratory capabilities, onboarding new scientific personnel and the deploymen...

 PRESS RELEASE

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commerci...

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale DENVER, March 18, 2026 (GLOBE NEWSWIRE) --  -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by researchers for its unusual combination of strength and elasticity. Kraig Biocraft Laboratories (OTCQB: KBLB) deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a Spring scale-up effort that could eventually produce around 10 metric tons of reco...

 PRESS RELEASE

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- -- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture rounds, institutional syndicates, and aggressive capital deployment strategies. But what happens when a company advances a platform with billion-dollar potential without the backing of Silicon Valley mega-funding? That question is increasingly being asked about Kraig Biocraft Laboratories (OTCQB: KBLB). More than a decade ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch